Thyroid and Cortisol Hormone Response to Sepsis - Trial NCT06289179

Name: Clinical Trial NCT06289179
Creator: Assiut University
Keywords: Sepsis, clinical trial

Access comprehensive clinical trial information for NCT06289179 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Sepsis. Target enrollment is 114 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

NCT06289179

Not yet recruiting

Trial Details

ClinicalTrials.gov • NCT06289179

View on ClinicalTrials.gov

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Thyroid and Cortisol Hormone Response to Sepsis

Thyroid and Cortisol Hormone Response in Patients With Sepsis Who Attended To Assiut University Hospitals (ICU)

Study Focus

Disease/Condition

Sepsis

Study Type

Observational

Sponsor & Location

Primary Sponsor

Assiut University

Timeline & Enrollment

Phase

N/A

Start Date

Mar 01, 2024

End Date

Oct 25, 2026

Enrollment

114 participants

Primary Outcome

Pattern of cortisol level and thyroid function response to sepsis in ICU

Summary

Thyroid and cortisol hormone response to sepsis

ICD-10 Classifications

Other sepsis

Sepsis, unspecified

Other specified sepsis

Candidal sepsis

Puerperal sepsis

Data Source

Registry

ClinicalTrials.gov

Trial ID

NCT06289179

Type

Non-Device Trial